期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
The therapeutic potential of probucol and probucol analogues in neurodegenerative diseases 被引量:1
1
作者 Arazu Sharif John Mamo +6 位作者 Virginie Lam Hani Al-Salami Armin Mooranian gerald f.watts Roger Clarnette Giuseppe Luna Ryu Takechi 《Translational Neurodegeneration》 CSCD 2024年第1期1023-1034,共12页
Neurodegenerative disorders present complex pathologies characterized by various interconnected factors,including the aggregation of misfolded proteins,oxidative stress,neuroinflammation and compromised blood-brain ba... Neurodegenerative disorders present complex pathologies characterized by various interconnected factors,including the aggregation of misfolded proteins,oxidative stress,neuroinflammation and compromised blood-brain barrier(BBB)integrity.Addressing such multifaceted pathways necessitates the development of multi-target therapeutic strategies.Emerging research indicates that probucol,a historic lipid-lowering medication,offers substantial potential in the realm of neurodegenerative disease prevention and treatment.Preclinical investigations have unveiled multifaceted cellular effects of probucol,showcasing its remarkable antioxidative and anti-inflammatory properties,its ability to fortify the BBB and its direct influence on neural preservation and adaptability.These diverse effects collectively translate into enhancements in both motor and cognitive functions.This review provides a comprehensive overview of recent findings highlighting the efficacy of probucol and probucol-related compounds in the context of various neurodegenerative conditions,including Alzheimer’s disease,Parkinson’s disease,Huntington’s disease,and cognitive impairment associated with diabetes. 展开更多
关键词 Neurodegenerative disease PROBUCOL Probucol analogues INFLAMMATION Blood-brain barrier Oxidative stress INFLAMMATION AMYLOID-BETA
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部